Development of a DN indication for pirfenidone (アイスーリュイ)
A development program for pirfenidone (アイスーリュイ) that involves filing an IND application for a diabetic nephropathy (DN) indication, undergoing evaluation by the Chinese authorities, and aiming to initiate a Phase 2 trial.
Companies1How many companies write about this.
Threads2One company can carry more than one thread here.